It is extremely difficult to develop targeted treatments for triple-negative breast (TNB) cancer, because these cells do not express any of the key biomarkers usually exploited for this goal.
from Most Recent Articles: Journal of Nanobiotechnology https://ift.tt/2I0MMzY
via IFTTT
No comments:
Post a Comment